Leon Tang
Founding Partner, In scienceWeTrust BioAdvisoryLeon Tang is the founder of In scienceWeTrust BioAdvisory (ISWT BioAdvisory), an East-West BD&L and R&D consulting firm that enables biotech companies and investment firms to maximise their potential through East-West biotech collaboration. He is also the founder of InScienceWeTrust Community (www.iswtc.org), an Asian biotech focused nonprofit with 4,000+ active members. At the same time, he is a seasonal scientific adviser at Mianus Capital and an adviser at BioSpark Group. Leon has a PhD in bioengineering and has published 50+ academic papers on Nature Reviews Drug Discovery, Lancet Oncology, Science Translational Medicine, Science Advances, and other leading academic journals.
Articles by Leon Tang
Economy
Why China’s biotech rise is harder to contain than AI
China is emerging as a biotech powerhouse, but its rise is entwined with US drugmakers through research, licensing and supply chains, making decoupling far more difficult than in AI. Academic Chen Xiangming and biopharma industry practitioner Leon Tang analyse the situation.
Chen Xiangming, Leon Tang
05 Aug 2026